Protalix BioTherapeutics (PLX) Change in Inventory (2010 - 2026)
Protalix BioTherapeutics (PLX) posted quarterly Change in Inventory of $4.7 million for Q1 2026, up 373.17% year-over-year from $1.0 million in Q1 2025, and up 6.06% quarter-over-quarter from $4.5 million in Q4 2025.
Protalix BioTherapeutics (PLX) Change in Inventory (2010 - 2026) Analysis & Trends
Protalix BioTherapeutics' Change in Inventory history runs 17 years deep, the most recent figure standing at $4.7 million for Q1 2026.
- In Q1 2026, Change in Inventory rose 373.17% year-over-year to $4.7 million; the TTM figure through Mar 2026 stood at $11.0 million (up 486.2% YoY), while the FY2025 annual figure was $4.5 million, up 104.09% from the prior year.
- Change in Inventory for Q1 2026 stood at $4.7 million, up from $4.5 million in the prior quarter.
- The five-year high for Change in Inventory was $4.7 million in Q1 2026, with the low at -$3.5 million in Q3 2024.
- The 5-year median for Change in Inventory is $124000.0 (2025), against an average of $736470.6.
- The sharpest annual moves came in 2023 and 2026: Change in Inventory plunged 667.82% in 2023, then soared 373.17% in 2026.
- Protalix BioTherapeutics' Change in Inventory stood at $2.2 million in 2022, then slumped by 213.2% to -$2.5 million in 2023, then soared by 259.34% to $4.0 million in 2024, then grew by 10.63% to $4.5 million in 2025, then advanced by 6.06% to $4.7 million in 2026.
- Business Quant data shows PLX's Change in Inventory at $4.7 million in Q1 2026, $4.5 million in Q4 2025, and $124000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.53 Bn | 130.68 Bn | 2.84 Bn | 27.70 Mn |
| 2 | Regeneron Pharmaceuticals | 86.34 Bn | 78.35 Bn | 3.93 Bn | 28.20 Mn |
| 3 | Argenx Se | 64.67 Bn | 59.48 Bn | 1.37 Bn | - |
| 4 | Moderna | 59.04 Bn | 53.90 Bn | 52.00 Mn | 132.00 Mn |
| 5 | BeOne Medicines | 42.03 Bn | 36.94 Bn | 1.53 Bn | 47.15 Mn |
| 6 | Alnylam Pharmaceuticals | 30.78 Bn | 27.47 Bn | 992.69 Mn | -280,000.00 |
| 7 | BioNTech SE | 27.81 Bn | 9.42 Bn | 668.28 Mn | 135.26 Mn |
| 8 | Insmed | 27.21 Bn | 26.05 Bn | 358.27 Mn | 12.97 Mn |
| 9 | Royalty Pharma | 26.99 Bn | 26.15 Bn | - | - |
| 10 | Protalix BioTherapeutics | 193.57 Mn | 152.91 Mn | 12.13 Mn | 1.82 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.82 Mn |
| Jun 30, 2026 | 1.82 Mn |
| Mar 31, 2026 | 4.75 Mn |
| Mar 31, 2026 | 4.75 Mn |
| Dec 31, 2025 | 4.47 Mn |
| Dec 31, 2025 | 4.47 Mn |
| Sep 30, 2025 | 124,000.00 |
| Sep 30, 2025 | 124,000.00 |
| Jun 30, 2025 | 1.63 Mn |
| Jun 30, 2025 | 1.63 Mn |
| Mar 31, 2025 | -1.74 Mn |
| Mar 31, 2025 | -1.74 Mn |
| Dec 31, 2024 | 4.04 Mn |
| Dec 31, 2024 | 4.04 Mn |
| Sep 30, 2024 | -3.52 Mn |
| Sep 30, 2024 | -3.52 Mn |
| Jun 30, 2024 | -1.63 Mn |
| Jun 30, 2024 | -1.63 Mn |
| Mar 31, 2024 | 3.30 Mn |
| Mar 31, 2024 | 3.30 Mn |